The absence of a Marvel film at the start of the 2024 summer movie season is a noticeable change from previous years. Since 2008, Marvel Cinematic Universe films have typically kicked off the summer movie season, consistently bringing in substantial box office numbers. This year, Universal’s “The Fall Guy” took the spotlight for the first
Business
Oddity Tech, a newly public Israeli cosmetics platform, has defied expectations in the beauty retail sector with its first-quarter results. The company, which utilizes artificial intelligence to develop products, reported earnings per share of 61 cents, adjusted, compared to the 49 cents that Wall Street was anticipating. Additionally, revenue for the quarter reached $211.63 million,
Former Starbucks CEO Howard Schultz recently commented on the coffee chain’s disappointing quarterly report, pointing out that the company’s U.S. stores need significant improvement to bounce back. Despite no longer holding an official position at Starbucks, Schultz identified a key factor contributing to the decline. He emphasized the need for enhancing the mobile order and
Amgen’s stock saw a significant rise of over 12% following the announcement of positive initial data on its innovative weight loss injection, MariTide. This news has sparked concerns among investors regarding new competition in the rapidly expanding weight loss drug market. As a result, shares of established players in the obesity treatment sector such as
Wayfair, the online furniture retailer, recently announced its first quarter results, showcasing a decline in sales but a reduction in losses after implementing a significant workforce reduction at the beginning of the year. Despite the sales decline, Wayfair managed to surpass Wall Street’s expectations in terms of both revenue and loss per share. The company
Johnson & Johnson recently announced its plan to pay $6.5 billion over 25 years to resolve the majority of lawsuits in the United States alleging that its talc-based products led to ovarian cancer. This move comes in the wake of mounting legal and financial challenges faced by the company due to these claims. Despite maintaining
In a significant legal development, a federal judge in New Jersey dismissed the legal challenges posed by Johnson & Johnson and Bristol Myers Squibb against the Biden administration’s Medicare drug-price negotiations. This ruling confirms the constitutionality of the program and represents a victory for the White House in its ongoing battle against major drug manufacturers.
As Paramount Global gears up to announce the departure of Chief Executive Officer Bob Bakish, the company is on the cusp of a major transformation. The move, strategically timed before an earnings report and potential merger agreement, has raised eyebrows among shareholders and industry insiders alike. While the exact reasons behind Bakish’s impending exit remain
The Food and Drug Administration recently approved Pfizer’s new treatment for a rare genetic bleeding disorder, marking a significant milestone for the company. The drug, known as Beqvez, is the first gene therapy from Pfizer to receive clearance in the United States. This innovative treatment is targeted towards adults with moderate to severe hemophilia B
In a move to broaden its specialty pharmacy services, Walgreens announced on Thursday that it will be collaborating directly with drugmakers to offer cell and gene therapies to patients in the United States. This initiative comes as the company launches a new business unit dedicated to its specialty pharmacy segment, which includes the specialty pharmacy